DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lotronex (Alosetron) - Adverse Event Reports - Hospitalization - Colitis Ischaemic

 



Index of reports > Cases resulting in hospitalization (5) > Cases with Colitis Ischaemic (3)

Below is the selection of adverse event reports related to Lotronex (Alosetron) that includes cases resulting in hospitalization where reactions include colitis ischaemic.

Adverse event in female receiving Lotronex (Alosetron)

Reported by a consumer/non-health professional from United States on 2007-06-19

Patient: female

Adverse reactions / side effects: Colitis Ischaemic, Haemorrhage, Rectal Haemorrhage, Pain

Adverse event resulted in: hospitalization

Suspect drug(s):
Lotronex (Alosetron)

Other drugs received by patient: Imodium; HRT; Blood Pressure Medication



Adverse event in 62 year old female receiving Lotronex (Alosetron)

Reported by a consumer/non-health professional from United States on 2007-06-14

Patient: 62 year old female, weighing 78.2 kg (172.0 pounds)

Adverse reactions / side effects: Abdominal Pain, Colitis Ischaemic, Ischaemia, Rectal Haemorrhage, Gastrointestinal Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Lotronex (Alosetron)

Other drugs received by patient: Estratest



Adverse event in 51 year old female receiving Lotronex (Alosetron)

Reported by a pharmacist from United States on 2007-05-30

Patient: 51 year old female, weighing 77.0 kg (169.4 pounds)

Adverse reactions / side effects: Colitis Ischaemic, Diarrhoea Haemorrhagic, Pyrexia

Adverse event resulted in: hospitalization

Suspect drug(s):
Lotronex
    Dosage: 0.5 mg every other day po
    Administration route: Oral
    Indication: Diarrhoea

Lotronex
    Dosage: 0.5 mg every other day po
    Administration route: Oral
    Indication: Irritable Bowel Syndrome

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009